-
公开(公告)号:US07868038B2
公开(公告)日:2011-01-11
申请号:US11848509
申请日:2007-08-31
申请人: Derek W. Nelson , Jennifer M. Frost
发明人: Derek W. Nelson , Jennifer M. Frost
IPC分类号: A61K31/381 , C07D495/18
CPC分类号: C07D495/18
摘要: The present invention relates to thiophene containing compounds of formula (I) wherein m, n, p, q, r, s, R1, R2, and R3 are as defined in the description. Included also are pharmaceutical compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and pharmaceutical compositions.
摘要翻译: 本发明涉及含噻吩的式(I)化合物,其中m,n,p,q,r,s,R 1,R 2和R 3如说明书中所定义。 还包括包含这些化合物的药物组合物,以及使用这些化合物和药物组合物治疗病症和障碍的方法。
-
2.
公开(公告)号:US20100093814A1
公开(公告)日:2010-04-15
申请号:US12274105
申请日:2008-11-19
申请人: Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
发明人: Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
IPC分类号: A61K31/426 , C07D277/28 , A61P25/00
CPC分类号: C07D277/46 , C07D277/28 , C07D277/48 , C07D277/60 , C07D277/82 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , C07D513/04 , C07D513/08
摘要: The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L1 are defined in the specfication, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1a, R2a, Rx, and n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译: 本发明涉及式(I)化合物或其药物盐,前体药物,前体药物或其组合的盐,其中R1,R2,R3,R4和L1在具体实施方案中定义,包含这些化合物的组合物和方法 使用这些化合物和组合物治疗病症和病症。 本发明还涉及式(II)化合物或其药物盐,前药,前体药物或其组合的盐,其中R 1a,R 2a,R x和n如说明书中所定义,包含这些化合物的组合物和方法 使用这些化合物和组合物治疗病症和病症。
-
公开(公告)号:US08546583B2
公开(公告)日:2013-10-01
申请号:US11755434
申请日:2007-05-30
申请人: Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
发明人: Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
IPC分类号: A61K31/426 , A61K31/427 , C07D417/06 , C07D417/14 , C07D277/44
CPC分类号: C07D277/82 , C07D277/46 , C07D277/48 , C07D277/60 , C07D417/06 , C07D417/12 , C07D477/14 , C07D513/04
摘要: The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L1 are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1a, R2a and (Rx)n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译: 本发明涉及式(I)化合物或其药物盐,前体药物,前体药物或其组合的盐,其中R1,R2,R3,R4和L1在说明书中定义,包含这些化合物的组合物和方法 使用这些化合物和组合物治疗病症和病症。 本发明还涉及式(II)化合物或其药物盐,前药,前体药物或其组合的盐,其中R 1a,R 2a和(R x)n如说明书中所定义,包含这些化合物的组合物和方法 使用这些化合物和组合物治疗病症和病症。
-
公开(公告)号:US07875639B2
公开(公告)日:2011-01-25
申请号:US11755884
申请日:2007-05-31
申请人: Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
发明人: Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
IPC分类号: A61K31/426 , A61K31/427 , A61K31/428 , A61K31/429 , C07D498/04 , C07D493/04 , C07D417/06 , C07D277/46 , C07D277/60 , C07D277/82
CPC分类号: C07D277/46 , A61K31/429 , C07D277/48 , C07D277/82 , C07D417/04 , C07D417/06 , C07D417/12 , C07D493/08 , C07D513/04
摘要: The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L2, are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译: 本发明涉及式(I)化合物或其药学上可接受的盐,前药,前体药物或其组合的盐,其中R1,R2,R3,R4和L2在说明书中定义,包含这些化合物的组合物, 以及使用这些化合物和组合物治疗病症和病症的方法。
-
公开(公告)号:US08859596B2
公开(公告)日:2014-10-14
申请号:US12560893
申请日:2009-09-16
申请人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Teodozyj Kolasa , Tongmei Li , Sridhar Peddi , Bo Liu , Arturo Perez-Medrano , Meena Patel , Xueqing Wang , Derek W. Nelson
发明人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Teodozyj Kolasa , Tongmei Li , Sridhar Peddi , Bo Liu , Arturo Perez-Medrano , Meena Patel , Xueqing Wang , Derek W. Nelson
IPC分类号: A61K31/433 , C07D285/12 , C07D405/12 , C07D413/14 , C07D413/12 , C07D403/12 , C07D405/14 , C07D409/14 , C07D417/12 , C07D285/135 , C07D231/40
CPC分类号: C07D405/12 , C07D231/40 , C07D285/135 , C07D403/12 , C07D405/14 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12
摘要: Disclosed herein are cannabinoid receptor ligands of formula (I) wherein A1, A5, Rx, X4, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.
摘要翻译: 本文公开了式(I)的大麻素受体配体,其中A1,A5,Rx,X4和z如说明书中所定义。 还公开了包含这些化合物的组合物,以及使用这些化合物和组合物治疗病症和障碍的方法。
-
公开(公告)号:US08841334B2
公开(公告)日:2014-09-23
申请号:US12274105
申请日:2008-11-19
申请人: Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson , Xueqing Wang
发明人: Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson , Xueqing Wang
IPC分类号: A61K31/426 , C07D277/08
CPC分类号: C07D277/46 , C07D277/28 , C07D277/48 , C07D277/60 , C07D277/82 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , C07D513/04 , C07D513/08
摘要: The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L1 are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1a, R2a, Rx, and n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译: 本发明涉及式(I)化合物或其药物盐,前体药物,前体药物或其组合的盐,其中R1,R2,R3,R4和L1在说明书中定义,包含这些化合物的组合物和方法 使用这些化合物和组合物治疗病症和病症。 本发明还涉及式(II)化合物或其药物盐,前药,前体药物或其组合的盐,其中R 1a,R 2a,R x和n如说明书中所定义,包含这些化合物的组合物和方法 使用这些化合物和组合物治疗病症和病症。
-
公开(公告)号:US08492371B2
公开(公告)日:2013-07-23
申请号:US12732421
申请日:2010-03-26
申请人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Tongmei Li , Bo Liu , Sridhar Peddi , Xueqing Wang , Teodozyj Kolasa , Derek W. Nelson , Arturo Perez-Medrano
发明人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Tongmei Li , Bo Liu , Sridhar Peddi , Xueqing Wang , Teodozyj Kolasa , Derek W. Nelson , Arturo Perez-Medrano
IPC分类号: A61K31/397 , A61K31/433 , A61K31/42 , A61K31/416 , A61K31/4155 , A61K31/422 , C07D205/02 , C07D285/12 , C07D261/02 , C07D231/10 , C07D231/54 , C07D263/02
CPC分类号: C07D417/06 , C07D405/06 , C07D413/06
摘要: Disclosed herein are compounds of formula (I) wherein Ring A and R1 are as defined in the specification. Pharmaceutical compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and pharmaceutical compositions are also disclosed.
摘要翻译: 本文公开了式(I)的化合物,其中环A和R 1如说明书中所定义。 还公开了包含这些化合物的药物组合物,以及使用这些化合物和药物组合物治疗病症和障碍的方法。
-
公开(公告)号:US08188135B2
公开(公告)日:2012-05-29
申请号:US12560897
申请日:2009-09-16
申请人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Teodozyj Kolasa , Tongmei Li , Sridhar Peddi , Bo Liu , Arturo Perez-Medrano , Meena Patel , Xueqing Wang , Derek W. Nelson
发明人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Teodozyj Kolasa , Tongmei Li , Sridhar Peddi , Bo Liu , Arturo Perez-Medrano , Meena Patel , Xueqing Wang , Derek W. Nelson
IPC分类号: A61K31/415 , C07D231/06
CPC分类号: C07D405/12 , C07D231/40 , C07D285/135 , C07D403/12 , C07D405/14 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12
摘要: Disclosed herein are cannabinoid receptor ligands of formula (I) wherein A1, A5, Rx, X4, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.
摘要翻译: 本文公开了式(I)的大麻素受体配体,其中A1,A5,Rx,X4和z如说明书中所定义。 还公开了包含这些化合物的组合物,以及使用这些化合物和组合物治疗病症和障碍的方法。
-
9.
公开(公告)号:US20110086855A1
公开(公告)日:2011-04-14
申请号:US12970480
申请日:2010-12-16
申请人: Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
发明人: Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
IPC分类号: A61K31/5377 , A61K31/426 , A61K31/4439 , A61K31/4709 , A61K31/506 , A61K31/428 , A61P29/00 , A61P25/00 , A61P35/00 , A61P11/00 , A61P9/00
CPC分类号: C07D277/46 , A61K31/429 , C07D277/48 , C07D277/82 , C07D417/04 , C07D417/06 , C07D417/12 , C07D493/08 , C07D513/04
摘要: The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L2, are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译: 本发明涉及式(I)化合物或其药学上可接受的盐,前药,前体药物或其组合的盐,其中R1,R2,R3,R4和L2在说明书中定义,包含这些化合物的组合物, 以及使用这些化合物和组合物治疗病症和病症的方法。
-
公开(公告)号:US20100249129A1
公开(公告)日:2010-09-30
申请号:US12732421
申请日:2010-03-26
申请人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Tongmei Li , Bo Liu , Sridhar Peddi , Xueqing Wang , Teodozyj Kolasa , Derek W. Nelson , Arturo Perez-Medrano
发明人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Tongmei Li , Bo Liu , Sridhar Peddi , Xueqing Wang , Teodozyj Kolasa , Derek W. Nelson , Arturo Perez-Medrano
IPC分类号: A61K31/433 , C07D417/08 , C07D417/06 , C07D405/06 , A61K31/443 , C07D413/06 , A61K31/422 , A61K31/4025 , A61K31/403 , C07D405/14 , C07D413/14 , A61K31/5377 , A61P29/00 , A61P25/00 , A61P37/02 , A61P11/00 , A61P35/00 , A61P9/00
CPC分类号: C07D417/06 , C07D405/06 , C07D413/06
摘要: Disclosed herein are compounds of formula (I) wherein Ring A and R1 are as defined in the specification. Pharmaceutical compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and pharmaceutical compositions are also disclosed.
摘要翻译: 本文公开了式(I)的化合物,其中环A和R 1如说明书中所定义。 还公开了包含这些化合物的药物组合物,以及使用这些化合物和药物组合物治疗病症和障碍的方法。
-
-
-
-
-
-
-
-
-